Martina (Tina) Diekmann Email & Phone Number
@newenglandpeptide.com
LinkedIn matched
Who is Martina (Tina) Diekmann? Overview
A concise factual answer block for searchers comparing this professional profile.
Martina (Tina) Diekmann is listed as Founder and CEO at MD Partners, based in Boston, Massachusetts, United States. AeroLeads shows a work email signal at newenglandpeptide.com and a matched LinkedIn profile for Martina (Tina) Diekmann.
Martina (Tina) Diekmann previously worked as President at Pht International, Inc. and Co-Founder at Uptides Bio. Martina (Tina) Diekmann holds Making Corporate Boards More Effective | Executive Education from Harvard Business School.
Email format at MD Partners
This section adds company-level context without repeating Martina (Tina) Diekmann's masked contact details.
AeroLeads found 1 current-domain work email signal for Martina (Tina) Diekmann. Compare company email patterns before reaching out.
About Martina (Tina) Diekmann
I bring enthusiasm, integrity and accountability to a company seeking a passionate, forward looking, and ambitious yet humble executive who is fun to work with.Life sciences CEO, board member, and executive leader of commercial organizations with a proven track record of delivering superior returns to investors. Grew businesses at above market growth rate. Experienced in larger/public, private equity-backed companies and start-ups. My focus is on go-to market strategies, portfolio management, operational execution, transformational change, and M&A. I bring a unique combination of a private equity CEO—with a successful exit—a strategist, business advisor, commercial excellence. CEO and member of the board of directors at Vivitide, a leading supplier of peptides, and Mytide Therapeutics, a biotech startup pioneering AI/ML enabled automated biopolymer manufacturing. Effective at growing revenue at above market growth rate in larger/public (Bachem) and private equity-backed companies (Vivitide–sold to KKR; Solvias). Increased earnings by focusing on most profitable segments and operational efficiency. Led M&A strategy and execution.Leading “from the front” in a collaborative style. Supporting flat hierarchies. Driving transformational change and empowering efficient decision making and execution. Leader of international, diverse teams. Ph.D. in chemistry. Leading strategic growth• Successfully developed businesses (public, PE owned CDMOs/CROs) • Recognized as "Manufacturer of the Year 2020" • Experienced in post-merger integration of acquired businesses• Delivered superior returns by setting & achieving strong growth objectives• Led organizational change, improvement; established best practices • Built a corporate culture of striving for moreM&A• Led acquisitions in Europe/USA from target identification to post-merger integration• Managed portfolio integration and grew acquired company’s revenue• As CEO grew company for sale by PE owners; led reverse due diligence to exitMarketing• Positioned company as life-science player and became designated as one of the top 5 global players• Received industry recognition: Swiss Campaign of the Year Gold Medal• Led transformation into a customer-centric organizationSales & Operations• Led all strategic and tactical aspects of global sales and business development, key account management, product management, business intelligence, customer relationship management, customer service.• Implemented sales & operations planning (S&OP) with +10 % points improvement in on-time delivery.
Listed skills include Publishing, Editing, Editorial, Publications, and 46 others.
Martina (Tina) Diekmann's current company
Company context helps verify the profile and gives searchers a useful next step.
Martina (Tina) Diekmann work experience
A career timeline built from the work history available for this profile.
President
CurrentPHT International is a Contract Development and Manufacturing Organization (CDMO) and Contract Research Organization (CRO) providing innovative solutions to leading life science companies. Founded in 1993, privately owned PHT builds long lasting partnerships with its customers through trust, honesty, and innovation. PHT’s manufacturing has been inspected by the FDA and clients' multiple times, building an organization committed to excellence in safety, quality, and compliance. With global sourcing capabilities, research and process development, scale up and compliant cGMP manufacturing, PHT aims to achieve complete suites of solutions that contribute to the health and protection of the world.
Co-Founder
CurrentUpTides Bio is specialized in optimizing natural products. We create unique molecules, that are active ingredients with enhanced efficacy and superior bio-physiological properties by applying the company's proprietary biological and chemical platform technology to design novel peptides and polynucleotides.
Founder & Ceo
CurrentLife sciences advisory specialized in corporate strategy (developing multi-year plans and roadmaps), commercial strategy (integrated sales and operations planning, S&OP), and execution (setting and monitoring key performance indicators, KPIs). Our expertise includes supporting start-up and new venture launch in business plan development, risk mitigation strategies, creating pitch decks and investor presentations. We excel in providing Venture Capital clients (VCs) and Private Equity firms (PEs) with guidance and services for M&A, including target identification, diligence support, post-merger integrations and offer direction regarding strategic partnerships. We enhance organizational development through systemic coaching of executives, enabling leaders to implement bold, high-impact solutions. We proudly support clients, offering tailored services to businesses and individuals at different stages as required.> Speaker: Women rising—how to elevate women in leadership roles (Boulder Peptide Symposium 2023)
Ceo | Member Of The Board Of Directors | Advisory Board Member
Joined the company full-time in 2023, after a 6 months tenure on the Advisory Board .Biotechnology startup, pioneering automated biopolymer manufacturing for cell therapy and drug discovery. Mytide's technology combines slug-flow manufacturing with AI/machine learning to accelerate the translation of innovative peptides into the clinic and beyond.
President | Ceo | Member Of The Board Of Directors
Private equity held CDMO. Supplier of custom peptides, antibodies, catalog products, proteomic tools for research and development (R&D) to the life sciences industry. The company was rebranded after the acquisition of 'New England Peptide' and 'Peptides International' by Ampersand in 2019.> Merged together and transformed the legacy businesses Peptides International and New England Peptides> Built a best-in-class commercial organization and expanded into new CRO/CDMO services> Enhanced operational performance and capacity utilization by implementing new processes and tools> Recognized for outstanding leadership in manufacturing (Manufacturer of the year, 2020)
Vice President Global Marketing
Publicly held market leading global CDMO ($5B market cap), specialized in the manufacturing of peptides, oligonucleotides and small molecule APIs.> Led global marketing, research chemicals sales, customer service, organization (team of about 45).> Responsible for revenue growth in North America, Europe and Asia (custom synthesis + catalog sales). > Established new sales & distribution channels, addressed new industries and emerging markets. > Headed strategic functions: business intelligence; digital marketing; science marketing; communications.> Evaluated new business opportunities and led diligence activities together with the CTO.> Led Sales and Operation planning (S&OP) meetings to optimize capacity utilization and internal alignment> SAP domain responsible for sales and distribution module for new ERP system / process improvements> Speaker: The customer journey: truth or dare? (Chemicals Sales & Marketing conference 2017).
Head Of Global Marketing
> Responsible for global marketing activities of the corporation.> Responsible for revenue growth of research chemicals (catalog and custom synthesis) segment.> Established a global, streamlined marketing organization; added talent to ensure market leadership.> Achieved turnaround and met revenue growth targets for business segment.> Drove top growth through product management (new product lines) and portfolio management.> Fully integrated American Peptide Company (customers, products) within one year after the acquisition.> Developed and launched a new eCommerce platform and digital marketing tools.> Rebranded the company as "Pioneering Partner for Peptides"; including positioning, corporate purpose, messaging and employer branding. > Speaker: Concepts and strategies for customer loyalty (Marketing Strategy & Technology Minds 2014)> Award: Gold medal 'Campaign of the year' for the corporate rebranding (Promo Swiss Award 2017)> Award: Sustainability award winner for the Bachem booth (CPhI Europe 2016)
Head Of Customer Management, Sales & Business Development (Europe; North America)
Solvias (a Novartis spinn-off) is a leader in contract research, development and manufacturing (CRO / CDMO) of small molecules and biopharmaceuticals for pharmaceutical, biotech and cosmetic companies.> Led sales, business development and customer service (team of 15) in Switzerland and the USA.> Defined and managed reorganization of the division in line with the new corporate strategy
Head Of Sales And Business Development (Europe)
> Led the Business Development and Key Account Management organization (team of 5)
Key Account Manager
> Developed—and executed—Key Account Management (KAM) strategy to mitigate revenue risk.> Managed all aspect of the business relationship with large, international companies.> Customer base ranged from pharmaceutical, chemical, agrochemical, to nutritional companies.> Established new long-term supply agreements with international validity.> Strengthened existing partnerships by integrating the company in the customers systems.> Drove revenue by cross-selling of the full service portfolio: analytical services, biopharmaceutical services, chemical development, catalysis services, custom synthesis, solid state services and process analytical technologies (PAT).
Sales & Business Development Manager
> Responsible for sales and business development in the life science industry from biotechs/start-ups to big-pharma in Central and Southern Europe
Project Manager
> Led professional training courses for life science industry: responsible for scientific content and lectures.
Head Of The Laboratory | Radiation Protection Officer
> Training and supervision of technicians, scientific coworkers and visiting scientists.> Overseeing lab operations and handling of radioactive chemicals as radiation safety officer.
Member Of The Advisory Board Of The Equal Opportunities (Dei) Officer
Postdoctoral Researcher
> In-vivo and ex-vivo testing of Adenosin receptor antagonists.
Visiting Scientist
Martina (Tina) Diekmann education
Making Corporate Boards More Effective | Executive Education
Phd, Pharmaceutical Chemistry
Systemic Coach & Change Manager
Chemistry | Diploma Thesis (Visiting Scientist)
Education record
Frequently asked questions about Martina (Tina) Diekmann
Quick answers generated from the profile data available on this page.
What company does Martina (Tina) Diekmann work for?
Martina (Tina) Diekmann works for MD Partners.
What is Martina (Tina) Diekmann's role at MD Partners?
Martina (Tina) Diekmann is listed as Founder and CEO at MD Partners.
What is Martina (Tina) Diekmann's email address?
AeroLeads has found 1 work email signal at @newenglandpeptide.com for Martina (Tina) Diekmann at MD Partners.
Where is Martina (Tina) Diekmann based?
Martina (Tina) Diekmann is based in Boston, Massachusetts, United States while working with MD Partners.
What companies has Martina (Tina) Diekmann worked for?
Martina (Tina) Diekmann has worked for Md Partners, Pht International, Inc., Uptides Bio, Mytide Therapeutics, and Vivitide (Aquired By Kkr | Biosynth).
How can I contact Martina (Tina) Diekmann?
You can use AeroLeads to view verified contact signals for Martina (Tina) Diekmann at MD Partners, including work email, phone, and LinkedIn data when available.
What schools did Martina (Tina) Diekmann attend?
Martina (Tina) Diekmann holds Making Corporate Boards More Effective | Executive Education from Harvard Business School.
What skills is Martina (Tina) Diekmann known for?
Martina (Tina) Diekmann is listed with skills including Publishing, Editing, Editorial, Publications, Public Relations, Social Media, Copywriting, and Copy Editing.
Search by job title, company, industry, location, and seniority. Export verified B2B contact data when you need it.
Start free trial